The authors describe a validation master plan for closed-vial filling technology.
Benoit Verjans
Advertisement
Articles by Benoit Verjans
The authors compare the exposure risk from viable particles from the air supply in four well-established aseptic filling technologies.
Advertisement
Latest Updated Articles
In-Depth Validation of Closed-Vial TechnologySeptember 1st 2012
Assessing Filling Technologies For Contamination RiskMarch 1st 2012
Advertisement
Advertisement
Trending on BioPharm International
1
ImvivaBio’s Dual-Target Allogeneic CAR-T Sustains Lupus Remission Through 12 Months
2
Updates on Simtra BioPharma Solutions’ Bloomington Capacity Expansions
3
Blackstone to Provide Pfizer Up to $1.5 Billion for Monthly GLP-1 Berobenatide Development
4
Amgen’s Dazodalibep Reduces Systemic Disease Activity in Phase 3 Sjögren’s Trial
5